Search research articles
Contact Us
Filters
Showing results (11-20 of 137) with videos related to
Page
of 14
Sort By:
Advances in Experimental Medicine and Biology
|
October 30, 2020
SRC Signaling in Cancer and Tumor Microenvironment
Ayse Caner, Elif Asik, Bulent Ozpolat
Nanomedicine (London, England)
|
April 23, 2016
Oligonucleotide-based theranostic nanoparticles in cancer therapy
Reza Shahbazi, Bulent Ozpolat, Kezban Ulubayram
Anticancer Research
|
May 29, 2017
Pancreatic Cancer Stem Cells and Therapeutic Approaches
Gulinnaz Ercan, Ayfer Karlitepe, Bulent Ozpolat
Cancers
|
November 27, 2024
Therapeutic Landscape of FOXM1 in Triple-Negative Breast Cancer and Aggressive Solid Cancers
Sayra Dilmac, Zuhal Hamurcu, Bulent Ozpolat
Advanced Drug Delivery Reviews
|
January 22, 2022
RNAi-based therapeutics and tumor targeted delivery in cancer
Goknur Kara, George A Calin, Bulent Ozpolat
Leukemia & Lymphoma
|
October 1, 2005
Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells
Bulent Ozpolat, Kapil Mehta, Gabriel Lopez-Berestein
Journal of Cellular and Molecular Medicine
|
March 20, 2015
Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth
Inan Olmez, Wangzhen Shen, Hayes McDonald, et al.
Oncotarget
|
February 27, 2016
FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells
Zuhal Hamurcu, Ahmed Ashour, Nermin Kahraman, et al.
Breast Cancer Research and Treatment
|
April 1, 2017
FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer
Zuhal Hamurcu, Nermin Kahraman, Ahmed Ashour, et al.
Advanced Drug Delivery Reviews
|
January 4, 2014
Liposomal siRNA nanocarriers for cancer therapy
Bulent Ozpolat, Anil K Sood, Gabriel Lopez-Berestein
Page
of 14
Search research articles
Search
Showing results (11-20 of 137) with videos related to
Sort By:
Page
of 14
Advances in Experimental Medicine and Biology
|
October 30, 2020
SRC Signaling in Cancer and Tumor Microenvironment
Ayse Caner, Elif Asik, Bulent Ozpolat
Nanomedicine (London, England)
|
April 23, 2016
Oligonucleotide-based theranostic nanoparticles in cancer therapy
Reza Shahbazi, Bulent Ozpolat, Kezban Ulubayram
Anticancer Research
|
May 29, 2017
Pancreatic Cancer Stem Cells and Therapeutic Approaches
Gulinnaz Ercan, Ayfer Karlitepe, Bulent Ozpolat
Cancers
|
November 27, 2024
Therapeutic Landscape of FOXM1 in Triple-Negative Breast Cancer and Aggressive Solid Cancers
Sayra Dilmac, Zuhal Hamurcu, Bulent Ozpolat
Advanced Drug Delivery Reviews
|
January 22, 2022
RNAi-based therapeutics and tumor targeted delivery in cancer
Goknur Kara, George A Calin, Bulent Ozpolat
Leukemia & Lymphoma
|
October 1, 2005
Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells
Bulent Ozpolat, Kapil Mehta, Gabriel Lopez-Berestein
Journal of Cellular and Molecular Medicine
|
March 20, 2015
Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth
Inan Olmez, Wangzhen Shen, Hayes McDonald, et al.
Oncotarget
|
February 27, 2016
FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells
Zuhal Hamurcu, Ahmed Ashour, Nermin Kahraman, et al.
Breast Cancer Research and Treatment
|
April 1, 2017
FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer
Zuhal Hamurcu, Nermin Kahraman, Ahmed Ashour, et al.
Advanced Drug Delivery Reviews
|
January 4, 2014
Liposomal siRNA nanocarriers for cancer therapy
Bulent Ozpolat, Anil K Sood, Gabriel Lopez-Berestein
Page
of 14